Literature DB >> 30719591

Discordant isolates in bone specimens from patients with recurrent foot osteomyelitis.

Neal R Barshes1,2, Cezarina Mindru3,4, Barbara W Trautner3,4, Maria C Rodriguez-Barradas3,4.   

Abstract

We compared paired operative bone cultures (initial operation and reoperation) for 35 patients who experienced foot osteomyelitis treatment failure at a single hospital. Concordance was poor (kappa = 0.180). Staphylococcus aureus, gram negatives, and anaerobes were the most common discordant bacteria seen at reoperation, while Enterococcus was the most persistent.

Entities:  

Keywords:  Bone biopsy; Diabetic foot infection; Osteomyelitis

Mesh:

Year:  2019        PMID: 30719591     DOI: 10.1007/s10096-019-03470-w

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Treatment Failure and Leg Amputation Among Patients With Foot Osteomyelitis.

Authors:  Neal R Barshes; Cezarina Mindru; Chester Ashong; Maria Rodriguez-Barradas; Barbara W Trautner
Journal:  Int J Low Extrem Wounds       Date:  2016-09-20       Impact factor: 2.057

2.  Oral antimicrobial therapy for diabetic foot osteomyelitis.

Authors:  John M Embil; Greg Rose; Elly Trepman; Mary Cheang M Math; Frank Duerksen; J Neil Simonsen; Lindsay E Nicolle
Journal:  Foot Ankle Int       Date:  2006-10       Impact factor: 2.827

3.  2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; Paul B Cornia; James C Pile; Edgar J G Peters; David G Armstrong; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Michael S Pinzur; Eric Senneville
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

4.  Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing.

Authors:  Michael Loesche; Sue E Gardner; Lindsay Kalan; Joseph Horwinski; Qi Zheng; Brendan P Hodkinson; Amanda S Tyldsley; Carrie L Franciscus; Stephen L Hillis; Samir Mehta; David J Margolis; Elizabeth A Grice
Journal:  J Invest Dermatol       Date:  2016-08-24       Impact factor: 8.551

5.  Primarily non-surgical management of osteomyelitis of the foot in diabetes.

Authors:  F L Game; W J Jeffcoate
Journal:  Diabetologia       Date:  2008-04-03       Impact factor: 10.122

Review 6.  Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment.

Authors:  A R Berendt; E J G Peters; K Bakker; J M Embil; M Eneroth; R J Hinchliffe; W J Jeffcoate; B A Lipsky; E Senneville; J Teh; G D Valk
Journal:  Diabetes Metab Res Rev       Date:  2008 May-Jun       Impact factor: 4.876

7.  Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study.

Authors:  Eric Senneville; Audrey Lombart; Eric Beltrand; Michel Valette; Laurence Legout; Marie Cazaubiel; Yazdan Yazdanpanah; Pierre Fontaine
Journal:  Diabetes Care       Date:  2008-01-09       Impact factor: 19.112

8.  Redefining the Chronic-Wound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing.

Authors:  Lindsay Kalan; Michael Loesche; Brendan P Hodkinson; Kristopher Heilmann; Gordon Ruthel; Sue E Gardner; Elizabeth A Grice
Journal:  MBio       Date:  2016-09-06       Impact factor: 7.867

9.  The neuropathic diabetic foot ulcer microbiome is associated with clinical factors.

Authors:  Sue E Gardner; Stephen L Hillis; Kris Heilmann; Julia A Segre; Elizabeth A Grice
Journal:  Diabetes       Date:  2012-11-08       Impact factor: 9.461

10.  The microbiome of diabetic foot osteomyelitis.

Authors:  S A V van Asten; J La Fontaine; E J G Peters; K Bhavan; P J Kim; L A Lavery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-15       Impact factor: 3.267

View more
  1 in total

1.  Polymicrobial Foot Infection Patterns Are Common and Associated With Treatment Failure.

Authors:  Neal R Barshes; Nicholas J Clark; Deeksha Bidare; J H Dudenhoeffer; Cezarina Mindru; Maria C Rodriguez-Barradas
Journal:  Open Forum Infect Dis       Date:  2022-09-15       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.